A system configured to cut leaflet tissue at a cardiac valve may comprise a guide catheter having a proximal end and a distal end, wherein the distal end of the guide catheter is steerable to a position above a cardiac valve. The system may also include a hook catheter having a proximal end and a distal end, the hook catheter configured to extend from the distal end of the guide catheter through a first orifice of the cardiac valve. Further, the system may comprise a cutting mechanism extending from the hook catheter, the cutting mechanism configured to cut a portion of leaflet tissue of the cardiac valve. Finally, the system may include a handle coupled to the proximal end of the guide catheter, the handle comprising at least one control operatively connected to the cutting mechanism.

A device configured to cut leaflet tissue at a cardiac valve may comprise a guide catheter having a proximal end and a distal end, the guide catheter being positionable at a cardiac valve. The device may further include a cutting mechanism routable through the guide catheter and configured to extend from the distal end of the guide catheter, the cutting mechanism configured to cut a portion of leaflet tissue of the cardiac valve. Finally, the device may comprise a handle coupled to the proximal end of the guide catheter, the handle comprising at least one control operatively connected to the cutting mechanism such that the at least one control is configured to provide selective actuation of the cutting mechanism.

The disclosure provides various embodiments of systems to facilitate the cutting of luminal tissue structures percutaneously.

A balloon aortic lithotripsy assembly for placement adjacent an aortic valve. The balloon aortic lithotripsy assembly includes multiple balloon chambers, a shell, and a shock wave generator. The balloon chambers are arranged to establish an open interior residing inboard of the balloon chambers. The shell is located around the balloon chambers. The shock wave generator can be situated on one or more of the balloon chambers, the shell, or both of the balloon chamber(s) and shell. In use, blood is free to travel through the open interior, and the shock wave generator can produce shock waves that are intended to impinge calcified tissues residing at the aortic valve.

A method for treating a treatment site (106) within or adjacent to a heart valve (108) within a body of a patient includes the steps of generating energy with an energy source (124); receiving energy from the energy source (124) with an energy guide (122A); positioning a balloon assembly (104) adjacent to the treatment site (106), the balloon assembly (104) including an outer balloon (104B) and an inner balloon (104A) that is positioned within and at least partially spaced-apart from the outer balloon (104B) to define an interstitial space (146A) therebetween that is configured to retain a balloon fluid (132); and positioning a portion of the energy guide (122A) that receives the energy from the energy source (124) within the interstitial space (146A) between the balloons (104A, 104B) so that a plasma-induced bubble (134) is formed in the balloon fluid (132) within the interstitial space (146A).

A catheter system for treating a treatment site within or adjacent to a vessel wall or a heart valve, includes a light source, a balloon, a light guide and an optical analyzer assembly. The light source generates first light energy. The balloon is positionable substantially adjacent to the treatment site. The balloon has a balloon wall that defines a balloon interior that receives a balloon fluid. The light guide receives the first light energy and guides the first light energy in a first direction from a guide proximal end toward a guide distal end positioned within the balloon interior. The optical analyzer assembly optically analyzes a second light energy from the light guide that moves in a second direction that is opposite the first direction. The optical analyzer assembly includes a safety shutdown system to inhibit the first light energy from being received by the guide proximal end of the light guide.

Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium, through the mitral valve, and into the left ventricle. A ventricular anchor is deployed from the catheter and into a wall of the left ventricle, leaving a ventricular suture attached to the ventricular anchor and extending proximally through the catheter. A leaflet anchor is deployed to secure a mitral valve leaflet to a leaflet suture, with the leaflet suture extending proximally through the catheter. The leaflet suture is secured to the ventricular suture to limit a range of travel of the leaflet in the direction of the left atrium. Also disclosed is an assembled in situ mitral valve leaflet restraint, having a neo papillary muscle and a neo chordae tendinea.

A catheter system for treating site within or adjacent to a vessel wall or a heart valve includes a light source, a first and second light guide, and an optical alignment system. The light source generates light energy. The first and second light guides receive the light energy from the light source and have respective guide proximal ends. A multiplexer directs the light energy toward the guide proximal ends of the first and second light guides. The optical alignment system determines an alignment of the light energy relative to at least one of the guide proximal ends and adjusts the positioning of the light energy relative to the at least one of the guide proximal ends based at least partially on the alignment of the light energy relative to the at least one of the guide proximal ends.

The invention is a device, system, and method for repairing heart valve function, which may include bisecting native valve leaflets for improved deployment of a prosthetic heart valve in the native valve annulus. The invention may include a catheter having a cutting element shaft with a cutting element configured to puncture a valve leaflet and/or make a controlled cut through the leaflet. The device may have an extendable foot configured to be positioned on an opposite side of the valve leaflet from the cutting element shaft. The device may include magnets to guide the cutting element and/or cutting element shaft in proper alignment with the extendable foot and to hold the elements in place during leaflet bisection.

A catheter system (100) for treating a treatment site (106) within or adjacent to a vessel wall (108A) or a heart valve. In various embodiments, the catheter system (100) includes a balloon (104) and an inflation tube (219, 319). The balloon (104) has a balloon interior (146). The inflation tube (219, 319) is configured to guide a flow of an inflation fluid (132) into the balloon interior (146). The inflation tube (219, 319) has an inflation lumen (319A). The inflation tube (219, 319) is movable between (i) an first configuration (319F) wherein the inflation lumen (319A) has a first cross-sectional area, and (ii) a second configuration (319S) wherein the inflation lumen (319A) has a second cross-sectional area that is less than the first cross-sectional area. In various alternative embodiments, the inflation tube (219, 319) can be biased toward the second configuration (319S) or the first configuration (319F). The inflation tube (219, 319) can include a tube wall (319W) that varies in thickness